PeptideDB

JAK-IN-3 1400876-94-9

JAK-IN-3 1400876-94-9

CAS No.: 1400876-94-9

JAK-IN-3 is a novel and potent JAK inhibitor with immuomodulatory (anti-inflammatory and anti-RA) activity. It inhibits
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

JAK-IN-3 is a novel and potent JAK inhibitor with immuomodulatory (anti-inflammatory and anti-RA) activity. It inhibits JAK3, JAK1, TYK2 and JAK2 with IC50 values of 3 nM, 5 nM, 34 nM and 70 nM, respectively.



Physicochemical Properties


Molecular Formula C18H20N4O3
Molecular Weight 340.38
Exact Mass 340.153
CAS # 1400876-94-9
PubChem CID 68291755
Appearance Light brown to brown solid powder
LogP 1.2
Hydrogen Bond Donor Count 4
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 6
Heavy Atom Count 25
Complexity 458
Defined Atom Stereocenter Count 2
SMILES

[C@H](NC1C2N(C=C(C3=CC=CC=C3)C=2)N=CC=1C(N)=O)([C@H](O)C)CO

InChi Key PRWQQLFMBINSAW-IAQYHMDHSA-N
InChi Code

InChI=1S/C18H20N4O3/c1-11(24)15(10-23)21-17-14(18(19)25)8-20-22-9-13(7-16(17)22)12-5-3-2-4-6-12/h2-9,11,15,21,23-24H,10H2,1H3,(H2,19,25)/t11-,15-/m1/s1
Chemical Name

4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]amino]-6-phenylpyrrolo[1,2-b]pyridazine-3-carboxamide
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid Arthritis. ACS Med Chem Lett. 2019 Feb 13;10(3):306-311.


Solubility Data


Solubility (In Vitro) DMSO : ~62.5 mg/mL (~183.62 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (6.11 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.9379 mL 14.6895 mL 29.3789 mL
5 mM 0.5876 mL 2.9379 mL 5.8758 mL
10 mM 0.2938 mL 1.4689 mL 2.9379 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.